On the other hand, in diseases such as Helicobacter pylori infection, hepatitis B and COVID-19, IL-22 induces disease progression by promoting local recruitment of inflammatory cells and secretion of proinflammatory cytokines. This evidence concerns the gene IL22 and hepatitis B virus infection.